Patrick Farrant

Greater London. Greater London Legal Chronicle. May 21, 2022

RQ Bio’s $157 Million Licence With AstraZeneca

By Giulia Di Palma

In UK Taylor Vinters, advised on the matter. Taylor Vinters advised RQ Bio with a team including Patrick Farrant (Picture – Life Science & Health Care)....

This content is for members only.
Join Now

Already a member? Log in here

Greater London. Greater London Legal Chronicle. March 14, 2022

DIOSynVax’s $42 Million Deal With CEPI

By Giulia Di Palma

In UK Taylor Vinters, advised on the matter. Taylor Vinters advised DIOSynVax with a team including Patrick Farrant (Picture – IP&IT). DIOSynVax agreed for a $42m...

This content is for members only.
Join Now

Already a member? Log in here

ALK-Abelló A/S’ Licensing Agreement with ARS Pharmaceuticals Inc.

HungryPanda’s $55 Million Funding and Refinancing Round

11x’s $50 Million Series B Funding Round

Christies Care’s Acquisition of Daisy Chain Home Support

Becky Adlington and Steve Parry Business Swim!’s MBO From JD Gyms Group

Lisheen H2 Energy Park Limited’s Agreement With Clean Power Hydrogen Group

Coigach Community Development Company’s Acquisition Of 7,900 Acres Of Tenanted Croft Land And Common Grazings

Robert P. Slight & Sons’ Sale to EOT

Connelly Group Holdings’ Acquisition of Scottish Security & Fire Systems

RoundShield’s Closing of Private Credit Fund RS Fund V

Deep Blue’s Launch of the First Stablecoin of DBUSD in Jersey

Phoenix Equity Partners’ £200 Million Launch of Growth Partnership Fund

TLT Appoints Madi Dacwy as a Partner In Its Projects, Infrastructure and Construction Team

McDermott Strengthens Global Private Equity Offering With New Hire in London

Curtis Boosts London Finance and Corporate Capability with Appointment of Partner Christopher Harrison

RQ Bio’s $157 Million Licence With AstraZeneca

DIOSynVax’s $42 Million Deal With CEPI